Non-Small Cell Lung Carcinoma
Item
diagnosis of non-small cell lung cancer
boolean
C0007131 (UMLS CUI [1])
Neoplasm Metastasis Advanced Locally
Item
locally advanced or metastatic disease
boolean
C0027627 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C1517927 (UMLS CUI [1,3])
Radiotherapy to thorax Definitive Patient need for | Radiotherapy to mediastinum Definitive Patient need for | Chemotherapy Patient need for
Item
requires definitive thoracic and mediastinal radiotherapy with concurrent chemotherapy
boolean
C4038705 (UMLS CUI [1,1])
C0443196 (UMLS CUI [1,2])
C0686904 (UMLS CUI [1,3])
C4049191 (UMLS CUI [2,1])
C0443196 (UMLS CUI [2,2])
C0686904 (UMLS CUI [2,3])
C0392920 (UMLS CUI [3,1])
C0686904 (UMLS CUI [3,2])
Radiotherapy Dose Planned Disease Gross
Item
total planned radiation dose to gross disease 60-80 gy
boolean
C0034620 (UMLS CUI [1,1])
C1301732 (UMLS CUI [1,2])
C0012634 (UMLS CUI [1,3])
C0439806 (UMLS CUI [1,4])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Exclusion Criteria | Gastrointestinal Diseases Resulting in Metabolism altered | Liver diseases Resulting in Metabolism altered | Kidney Diseases Resulting in Metabolism altered | Gastrointestinal Diseases Resulting in Excretion Investigational New Drugs | Liver diseases Resulting in Excretion Investigational New Drugs | Kidney Diseases Resulting in Excretion Investigational New Drugs | Operation on gastrointestinal tract Major | Gastrectomy | Gastrostomy | Bowel resection
Item
no diagnosis of disease of the gastrointestinal (gi) system, liver, or kidneys that could result in altered metabolism or excretion of the study medication (e.g., history of major gi tract surgery, gastrectomy, gastrostomy, or bowel resection)
boolean
C0680251 (UMLS CUI [1])
C0017178 (UMLS CUI [2,1])
C0332294 (UMLS CUI [2,2])
C0025519 (UMLS CUI [2,3])
C0392747 (UMLS CUI [2,4])
C0023895 (UMLS CUI [3,1])
C0332294 (UMLS CUI [3,2])
C0025519 (UMLS CUI [3,3])
C0392747 (UMLS CUI [3,4])
C0022658 (UMLS CUI [4,1])
C0332294 (UMLS CUI [4,2])
C0025519 (UMLS CUI [4,3])
C0392747 (UMLS CUI [4,4])
C0017178 (UMLS CUI [5,1])
C0332294 (UMLS CUI [5,2])
C0221102 (UMLS CUI [5,3])
C0013230 (UMLS CUI [5,4])
C0023895 (UMLS CUI [6,1])
C0332294 (UMLS CUI [6,2])
C0221102 (UMLS CUI [6,3])
C0013230 (UMLS CUI [6,4])
C0022658 (UMLS CUI [7,1])
C0332294 (UMLS CUI [7,2])
C0221102 (UMLS CUI [7,3])
C0013230 (UMLS CUI [7,4])
C0399610 (UMLS CUI [8,1])
C0205164 (UMLS CUI [8,2])
C0017118 (UMLS CUI [9])
C0017196 (UMLS CUI [10])
C0741614 (UMLS CUI [11])
Exclusion Criteria | Gastrointestinal Diseases | Ulcerative Colitis | Regional enteritis | Gastrointestinal Hemorrhage
Item
no history of chronic gi disorders (e.g., ulcerative colitis, regional enteritis, or gi bleeding)
boolean
C0680251 (UMLS CUI [1])
C0017178 (UMLS CUI [2])
C0009324 (UMLS CUI [3])
C0678202 (UMLS CUI [4])
C0017181 (UMLS CUI [5])
Exclusion Criteria | Hypersensitivity Flaxseed | Hypersensitivity Flaxseed Metabolite | Hypersensitivity Wheat product
Item
no known hypersensitivity to flaxseed or any of its metabolites or to wheat products
boolean
C0680251 (UMLS CUI [1])
C0020517 (UMLS CUI [2,1])
C0023753 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0023753 (UMLS CUI [3,2])
C0870883 (UMLS CUI [3,3])
C0020517 (UMLS CUI [4,1])
C1532958 (UMLS CUI [4,2])
Therapeutic procedure
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
ID.10
Item
see disease characteristics
boolean
ID.11
Item
see patient characteristics
boolean
Investigational New Drugs Exclusion
Item
more than 14 days since prior and no concurrent investigational drugs
boolean
C0013230 (UMLS CUI [1,1])
C2828389 (UMLS CUI [1,2])
Exclusion Criteria | Amifostine | Mucomyst | Acetylcysteine
Item
more than 14 days since prior and no concurrent amifostine or mucomyst (n-acetylcysteine)
boolean
C0680251 (UMLS CUI [1])
C0015020 (UMLS CUI [2])
C0699252 (UMLS CUI [3])
C0001047 (UMLS CUI [4])
Radiotherapy to thorax Exclusion
Item
no prior thoracic radiotherapy
boolean
C4038705 (UMLS CUI [1,1])
C2828389 (UMLS CUI [1,2])
Exclusion Criteria | Flaxseed | Products Containing Flax | Soybeans | Products Containing Soy
Item
no prior or other concurrent flaxseed, flax-containing products, soybeans, or soy-containing products
boolean
C0680251 (UMLS CUI [1])
C0023753 (UMLS CUI [2])
C1514468 (UMLS CUI [3,1])
C0332256 (UMLS CUI [3,2])
C0023753 (UMLS CUI [3,3])
C0037733 (UMLS CUI [4])
C1514468 (UMLS CUI [5,1])
C0332256 (UMLS CUI [5,2])
C2756587 (UMLS CUI [5,3])
Exclusion Criteria | Dietary Supplements | Herbal Preparations | Botanicals
Item
no other concurrent dietary supplements, such as herbals or botanicals
boolean
C0680251 (UMLS CUI [1])
C0242295 (UMLS CUI [2])
C0949854 (UMLS CUI [3])
C1456557 (UMLS CUI [4])
Vitamins | Multivitamins | Calcium | Vitamin D
Item
vitamins or multivitamins, including calcium and vitamin d, are allowed
boolean
C0042890 (UMLS CUI [1])
C0301532 (UMLS CUI [2])
C0006675 (UMLS CUI [3])
C0042866 (UMLS CUI [4])